Melissa Prentiss

Discovery of 4-((2 <i>S</i> ,4 <i>S</i> )-4-Ethoxy-1-((5-methoxy-7-methyl-1 <i>H</i> -indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases

Nello Mainolfi, Takeru Ehara, Rajeshri G. Karki et al. · Journal of Medicinal Chemistry · 2020 · 60 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Long-acting protein drugs for the treatment of ocular diseases

Joy G. Ghosh, Andrew Nguyen, Chad E. Bigelow et al. · Nature Communications · 2017 · 54 citations · Full text

Pharmacy, Ophthalmology, Pharmacology +17

The Hierarchy of Proinflammatory Cytokines in Ocular Inflammation

Andre Pires da Cunha, Qin Zhang, Melissa Prentiss et al. · Current Eye Research · 2017 · 41 citations · Full text

Medicine, Immunology, Ophthalmology +17

Application of Imaging Mass Spectrometry to Assess Ocular Drug Transit

Kerri J. Grove, Viral Kansara, Melissa Prentiss et al. · SLAS DISCOVERY · 2017 · 18 citations · Full text

Medicine, Ophthalmology, Pharmacology +16

Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway

Rajeshri G. Karki, James J. Powers, Nello Mainolfi et al. · Journal of Medicinal Chemistry · 2019 · 16 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17